Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001718108-21-000034
Filing Date
2021-11-04
Accepted
2021-11-04 07:07:20
Documents
67
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-20210930.htm   iXBRL 10-Q 1303019
2 EX-10.2 surf-09302021xexx102.htm EX-10.2 21087
3 EX-31.1 surf-09302021xexx311.htm EX-31.1 10216
4 EX-31.2 surf-09302021xexx312.htm EX-31.2 10016
5 EX-32.1 surf-09302021xexx321.htm EX-32.1 5155
6 EX-32.2 surf-09302021xexx322.htm EX-32.2 4863
  Complete submission text file 0001718108-21-000034.txt   6260403

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20210930.xsd EX-101.SCH 43581
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT surf-20210930_cal.xml EX-101.CAL 55796
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT surf-20210930_def.xml EX-101.DEF 248595
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20210930_lab.xml EX-101.LAB 585283
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20210930_pre.xml EX-101.PRE 382598
12 EXTRACTED XBRL INSTANCE DOCUMENT surf-20210930_htm.xml XML 927953
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 211377962
SIC: 2836 Biological Products, (No Diagnostic Substances)